Publications by authors named "William Bensen"

Claim this Profile
T
Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety.
Paul Bird, William Bensen, Bassel El-Zorkany, Jeffrey Kaine, Bernadette Heizel Manapat-Reyes

J Clin Rheumatol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting.
Arthur N Lau, Matthew Wong-Pack, Rod Rodjanapiches, George Ioannidis, Sally Wade, William G Bensen, Robert Bensen

J Rheumatol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.
Hubert G Nüßlein, Rieke Alten, Mauro Galeazzi, Hanns-Martin Lorenz, Michael T Nurmohamed, William G Bensen

Clin Exp Rheumatol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis.
Proton Rahman, Denis Choquette, William G Bensen, Majed Khraishi, Andrew Chow

BMJ Open· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program.
Alexandra Papaioannou, Aliya Khan, Andre Belanger, William Bensen, David Kendler

Curr Med Res Opin· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Noncompliance to Prolia (Denosumab) on the Changes in Bone Mineral Density: A Retrospective Review.
Matthew Wong-Pack, Aashish Kalani, Jacob Hordyk, George Ioannidis, Robert Bensen, William G Bensen

J Osteoporos· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study.
Rieke Alten, Hubert Nüßlein, Mauro Galeazzi, Hanns-Martin Lorenz, Michael T Nurmohamed, William G Bensen

RMD Open· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of corticosteroids in patients with rheumatoid arthritis treated with infliximab: treatment implications based on a real-world Canadian population.
Boulos Haraoui, Algis Jovaisas, William G Bensen, Rafat Faraawi, John Kelsall

RMD Open· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Reliability of a Semiautomated Segmentation Algorithm for Quantifying Erosions in the Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis.
Michael A Tomizza, Matthew A Jessome, Joshua Barbosa, Karen A Beattie, William G Bensen

J Rheumatol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.
Vivian P Bykerk, Andrew J K Östör, José Alvaro-Gracia, Karel Pavelka, José Andrés Román Ivorra, William Bensen

Clin Rheumatol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Management of Infusion Reactions to Infliximab in a Prospective Real-world Community Registry.
Denis Choquette, Rafat Faraawi, Andrew Chow, Jude Rodrigues, William J Bensen

J Rheumatol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study.
Hubert G Nüßlein, Rieke Alten, Mauro Galeazzi, Hanns-Martin Lorenz, Michael T Nurmohamed, William G Bensen

BMC Musculoskelet Disord· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.
Vivian P Bykerk, Andrew J K Östör, José Alvaro-Gracia, Karel Pavelka, José Andrés Román Ivorra, William Bensen

Clin Rheumatol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of infliximab in rheumatoid arthritis: analysis from a Canadian multicenter prospective observational registry.
Carter Thorne, William G Bensen, Denis Choquette, Andrew Chow, Majed Khraishi

Arthritis Care Res (Hoboken)· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial.
Ruben Tavares, Karen Anne Beattie, William George Bensen, Raja S Bobba, Alfred A Cividino

Trials· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating rheumatoid arthritis to target: a Canadian patient survey.
Boulos Haraoui, William Bensen, Carter Thorne, John Wade, Melissa Deamude

J Clin Rheumatol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study.
Hubert G Nüßlein, Rieke Alten, Mauro Galeazzi, Hanns-Martin Lorenz, Dimitrios Boumpas, William G Bensen

BMC Musculoskelet Disord· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.
Jean-Yves Reginster, Janusz Badurski, Nicholas Bellamy, William Bensen, Roland Chapurlat

Ann Rheum Dis· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice.
Vivian P Bykerk, Andrew J K Ostör, José Alvaro-Gracia, Karel Pavelka, José Andrés Román Ivorra, William Bensen

Ann Rheum Dis· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating rheumatoid arthritis to target: a Canadian physician survey.
Boulos Haraoui, William Bensen, Louis Bessette, Sharon Le Clercq, Carter Thorne

J Rheumatol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial.
Cyrus Cooper, Jean-Yves Reginster, Roland Chapurlat, Claus Christiansen, Harry Genant, William Bensen

Curr Med Res Opin· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian recommendations for clinical trials of pharmacologic interventions in rheumatoid arthritis: inclusion criteria and study design.
Jacob Karsh, Edward C Keystone, Boulos Haraoui, J Carter Thorne, Janet E Pope, William G Bensen

J Rheumatol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial.
Dafna D Gladman, Claire Bombardier, Carter Thorne, Boulos Haraoui, Majed Khraishi, William Bensen

J Rheumatol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis.
Mario H Cardiel, Paul P Tak, William Bensen, Francis X Burch, Sarka Forejtova

Arthritis Res Ther· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain.
André D Beaulieu, Paul Peloso, William Bensen, Alexander J Clark, C Peter N Watson

Clin Ther· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis